Selinexor Enhances NK Cell Activation Against Malignant B Cells via Downregulation of HLA-E
Jack G. Fisher(University of Southampton), Matthew D. Blunt(University of Southampton)
Cited by 22
Related Papers
The Dual Syk/JAK Inhibitor Cerdulatinib Antagonizes B-cell Receptor and Microenvironmental Signaling in Chronic Lymphocytic Leukemia
|Clinical Cancer Research|2016|64